Health committee  Yes, I would. I can give you an example. Ilse mentioned and I mentioned the lack of funding. There's the lack of funding in terms of creating early-stage companies and getting them to the point where they can get the interest of international customers, international companies that may be strategic partners or may buy them out.

Health committee  I beg your pardon. No problem.

Health committee  Thank you for inviting me to speak to you today. It's a privilege and a welcome opportunity. In my first 10 minutes I would like to discuss three main themes: first, that innovation and invention are different, and that difference matters; second, that Canada is in some ways well behind world leaders in medical technology innovation; and third, that there are solutions, we have made progress, and the federal government can play a critical role.